4.7 Article

Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 25, Issue 24, Pages 6427-6434

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2017.10.015

Keywords

Allosteric modulator; CB1 receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element

Funding

  1. University of Pisa Italy (Progetti di Ricerca di Ateneo) [PRA_2017_51]
  2. National Institute on Drug Abuse - United States [R01DA023204, R01DA035926, P30DA013429]

Ask authors/readers for more resources

In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available